Recombinant human coronavirus SARS-CoV-2 Spike Glycoprotein RBD (Active)
Be the first to review this product! Submit a review
|
(9 Publications)
Recombinant human coronavirus SARS-CoV-2 Spike Glycoprotein RBD (Active) is a SARS-CoV-2 Fragment protein, in the 319 to 541 aa range, expressed in CHO cells, with >90%, suitable for SDS-PAGE, ELISA, Flow Cyt, FuncS.
View Alternative Names
2, S, Spike glycoprotein, S glycoprotein, E2, Peplomer protein
- Flow Cyt
Supplier Data
Flow Cytometry - Recombinant human coronavirus SARS-CoV-2 Spike Glycoprotein RBD (Active) (AB273065)
Flow cytometry assay showing ab273065 can bind to ACE2 overexpressing cells. ACE2 overexpressing cells were labelledwith ab273065, followed by an anti-spike protein antibody, and a fluorescence-conjugated secondary antibody.
- FuncS
Supplier Data
Functional Studies - Recombinant human coronavirus SARS-CoV-2 Spike Glycoprotein RBD (Active) (AB273065)
Binding ability measured in a funstional ELISA. Immobilized Human ACE2 protein at 2 ug/ml (100 ul/well) can bind to ab273065.
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant human coronavirus SARS-CoV-2 Spike Glycoprotein RBD (Active) (AB273065)
SDS-PAGE analysis of ab273065.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The SARS-CoV-2 Spike Glycoprotein RBD initiates attachment to host cells by specifically binding to the ACE2 receptor facilitating viral entry. The RBD is part of a larger trimeric complex where each monomer consists of an S1 and S2 domain. The S1 domain which includes the RBD is important for receptor binding while the S2 domain aids in membrane fusion. By mediating these initial interactions with host cells the RBD dictates the entry and infectivity of the virus.
Pathways
The interaction of the SARS-CoV-2 RBD with ACE2 is an important event in the entry pathways of the virus. This interaction triggers a cascade of events leading to endocytosis and viral replication. The virus utilizes the cellular machinery by hijacking the ACE2-mediated entry pathway which involves proteolytic processing by transmembrane protease serine 2 (TMPRSS2). The RBD's role connects closely with these proteins playing a vital part in both viral fusion and endocytosis pathways.
Specifications
Form
Liquid
Additional notes
Purity is lot specific. Please contact our technical Support team for details.
General info
Function
Spike protein S1. Attaches the virion to the cell membrane by interacting with host receptor, initiating the infection. The major receptor is host ACE2 (PubMed : 32142651, PubMed : 32155444, PubMed : 33607086). When S2/S2' has been cleaved, binding to the receptor triggers direct fusion at the cell membrane (PubMed : 34561887). When S2/S2' has not been cleaved, binding to the receptor results in internalization of the virus by endocytosis leading to fusion of the virion membrane with the host endosomal membrane (PubMed : 32075877, PubMed : 32221306). Alternatively, may use NRP1/NRP2 (PubMed : 33082294, PubMed : 33082293) and integrin as entry receptors (PubMed : 35150743). The use of NRP1/NRP2 receptors may explain the tropism of the virus in human olfactory epithelial cells, which express these molecules at high levels but ACE2 at low levels (PubMed : 33082293). The stalk domain of S contains three hinges, giving the head unexpected orientational freedom (PubMed : 32817270).. Spike protein S2. Precursor of the fusion protein processed in the biosynthesis of the S protein and the formation of virus particle. Mediates fusion of the virion and cellular membranes by functioning as a class I viral fusion protein. Contains two viral fusion peptides that are unmasked after cleavage. The S2/S2' cleavage occurs during virus entry at the cell membrane by host TMPRSS2 (PubMed : 32142651) or during endocytosis by host CSTL (PubMed : 32703818, PubMed : 34159616). In either case, this triggers an extensive and irreversible conformational change leading to fusion of the viral envelope with the cellular cytoplasmic membrane, releasing viral genomic RNA into the host cell cytoplasm (PubMed : 34561887). Under the current model, the protein has at least three conformational states : pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During fusion of the viral and target cell membranes, the coiled coil regions (heptad repeats) adopt a trimer-of-hairpins structure and position the fusion peptide in close proximity to the C-terminal region of the ectodomain. Formation of this structure appears to promote apposition and subsequent fusion of viral and target cell membranes.. Spike protein S2'. Subunit of the fusion protein that is processed upon entry into the host cell. Mediates fusion of the virion and cellular membranes by functioning as a class I viral fusion protein. Contains a viral fusion peptide that is unmasked after S2 cleavage. This cleavage can occur at the cell membrane by host TMPRSS2 or during endocytosis by host CSTL (PubMed : 32703818, PubMed : 34159616). In either case, this triggers an extensive and irreversible conformational change that leads to fusion of the viral envelope with the cellular cytoplasmic membrane, releasing viral genomic RNA into the host cell cytoplasm (PubMed : 34561887). Under the current model, the protein has at least three conformational states : pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During fusion of the viral and target cell membranes, the coiled coil regions (heptad repeats) adopt a trimer-of-hairpins structure and position the fusion peptide in close proximity to the C-terminal region of the ectodomain. Formation of this structure appears to promote apposition and subsequent fusion of viral and target cell membranes.
Sequence similarities
Belongs to the betacoronaviruses spike protein family.
Post-translational modifications
The cytoplasmic Cys-rich domain is palmitoylated. Palmitoylated spike proteins drive the formation of localized ordered cholesterol and sphingo-lipid-rich lipid nanodomains in the early Golgi, where viral budding occurs.. Specific enzymatic cleavages in vivo yield mature proteins. The precursor is processed into S1 and S2 by host furin or unknown proteases to yield the mature S1 and S2 proteins (PubMed:32155444, PubMed:32362314, PubMed:32703818, PubMed:34159616, PubMed:34561887). Processing between S2 and S2' occurs either by host CTSL in endosomes (PubMed:32221306, PubMed:33465165, PubMed:34159616), or by host TMPRSS2 at the cell surface (PubMed:32142651). Both cleavages are necessary for the protein to be fusion competent (PubMed:32703818, PubMed:34159616, PubMed:34561887). Cell surface activation allows the virus to enter the cell despite inhibition of the endosomal pathway by hydroxychloroquine (PubMed:33465165). The polybasic furin cleavage site is absent in SARS-CoV S (PubMed:32155444, PubMed:32362314, PubMed:33465165). It increases the dependence on TMPRSS2 expression by SARS-CoV-2 (PubMed:33465165). D614G substitution would enhance furin cleavage at the S1/S2 junction (PubMed:33417835).. Highly decorated by heterogeneous N-linked glycans protruding from the trimer surface (PubMed:32075877, PubMed:32155444, PubMed:32929138). Highly glycosylated by host both on S1 and S2 subunits, occluding many regions across the surface of the protein (PubMed:32363391, PubMed:32366695, PubMed:32929138). Approximately 40% of the protein surface is shielded from antibody recognition by glycans, with the notable exception of the ACE2 receptor binding domain (PubMed:32929138).. O-glycosylated by host GALNT1 at the end of S1. This could reduce the efficiency of S1/S2 cleavage.
Target data
Publications (9)
Recent publications for all applications. Explore the full list and refine your search
International journal of molecular sciences 24: PubMed37298438
2023
Applications
Unspecified application
Species
Unspecified reactive species
Sensors (Basel, Switzerland) 23: PubMed37112287
2023
Applications
Unspecified application
Species
Unspecified reactive species
ACS applied materials & interfaces 14:54527-54538 PubMed36454041
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of King Saud University. Science 34:102296 PubMed36062198
2022
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 8:eabn2378 PubMed36001655
2022
Applications
Unspecified application
Species
Unspecified reactive species
Function (Oxford, England) 3:zqac002 PubMed35284826
2022
Applications
Unspecified application
Species
Unspecified reactive species
BioMed research international 2021:6614000 PubMed34337036
2021
Applications
Unspecified application
Species
Unspecified reactive species
ACS nano 15:11743-11752 PubMed34128653
2021
Applications
Unspecified application
Species
Unspecified reactive species
ACS sensors 6:1270-1278 PubMed33629833
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com